Sun Pharmaceutical is currently trading at Rs. 489.55, up by 7.05 points or 1.46% from its previous closing of Rs. 482.50 on the BSE.
The scrip opened at Rs. 485.90 and has touched a high and low of Rs. 491.50 and Rs. 485.00 respectively. So far 57888 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 512.55 on 09-Jun-2020 and a 52 week low of Rs. 315.20 on 23-Mar-2020.
Last one week high and low of the scrip stood at Rs. 496.20 and Rs. 469.40 respectively. The current market cap of the company is Rs. 117387.46 crore.
The promoters holding in the company stood at 54.69%, while Institutions and Non-Institutions held 32.81% and 12.50% respectively.
Sun Pharmaceutical Industries’ wholly owned subsidiary company -- Taro Pharmaceutical Industries has agreed to acquire by way of purchase of all outstanding shares of Aquinox Pharmaceuticals (Canada) Inc., a corporation organized and existing under the laws of the Province of British Columbia that carries on the business of research and development of pharmaceutical products for purposes of their commercialization. Cash consideration of $8.2 million would be paid for acquisition of all shares.
Sun Pharma is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1786.05 |
Dr. Reddys Lab | 1354.20 |
Cipla | 1470.05 |
Lupin | 2190.50 |
Zydus Lifesciences | 1004.05 |
View more.. |